between development and approval all biotechs are purely speculative. Market generally bets against success thus risk reward opportunity as things play out.
As Index mentioned we were AML company and small enough to handle that at the time. Now we have cardio and FTO drop, it’s a different ball game.
Adjusting my timeline expectations based on that. If you assume 8-10 years and work backwards to discovery we are running at a fast past, although it appears not fast enough for some.
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-67
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
-0.005(0.28%) |
Mkt cap ! $306.5M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.83 | $1.80 | $87.03K | 48.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14868 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 700 | 1 |
View Market Depth
| Last trade - 14.25pm 28/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |